Download PDF
Neuropediatrics 2001; 32(5): 225-230
DOI: 10.1055/s-2001-19115
Original Article

Georg Thieme Verlag Stuttgart · New York

Non-Neoplastic Brain Abnormalities on MRI in Children and Adolescents with Neurofibromatosis Type 1

R. Raininko1 , L. Thelin2 , O. Eeg-Olofsson2
  • 1 Department of Oncology, Radiology and Clinical Immunology, Section of Radiology, Uppsala University, Uppsala, Sweden
  • 2 Department of Women's and Children's Health, Section for Pediatrics, Uppsala University, Uppsala, Sweden
Further Information

Publication History

Publication Date:
18 December 2001 (online)

    Permissions and Reprints

Abstract

The occurrence, localization and longitudinal course of non-neoplastic MRI abnormalities in children and adolescents with neurofibromatosis type 1 (NF 1) were studied. Thirty-five patients who satisfied the criteria for NF 1 underwent 114 MRI examinations. They were 9 months to 18 years old at their first examination, and 23 were examined more than once (2 - 11 times). The follow-up time varied from 3 months to 10 years (mean 4 years). Thirty-one patients (89 %) showed focal high signal intensities on T2-weighted images in the cerebellum, brain stem, deep cerebral gray matter and, less frequently, in the cerebral white matter. Changes were also seen in 80 % and 50 % of the proton density-weighted and T1-weighted images, respectively. Newly appearing, growing, decreasing and disappearing lesions occurred contemporaneously and in all ages. New lesions still developed in the late teens. Three lesions showed temporary contrast enhancement. Five expansive lesions were found in four individuals without related clinical symptoms. Four of them receded during follow-up. These cases indicate that the differential diagnosis between neoplastic and non-neoplastic lesions is not clear. The results support the view that high T2-signal lesions are so common in NF 1 that they should be included as another criterion for the diagnosis.

Key words

Neurofibromatosis type 1 - Brain - MRI - Non-neoplastic lesions

References

  • 1 Aoki S, Barkovich A J, Nishimura K, Kjos B O, Machida T, Cogen P. et al . Neurofibromatosis types 1 and 2: Cranial MR findings.  Radiology. 1989;  172 527-534
    PubMedGoogle Scholar
  • 2 Autti T, Raininko R, Vanhanen S L, Kallio M, Santavuori P. MRI of the normal brain from early childhood to middle age. I. Appearances of T2- and proton density-weighted images and occurrence of incidental high-signal foci.  Neuroradiology. 1994;  36 644-648
    CrossrefPubMedGoogle Scholar
  • 3 Barker D, Wright E, Nguyen K, Cannon L, Fain P, Goldgar D. et al . Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.  Science. 1989;  236 1100-1102
    PubMedGoogle Scholar
  • 4 Bilaniuk L T, Molloy P T, Zimmerman R A, Philips P C, Vaughan S N, Liu G T. et al . Neurofibromatosis type 1: brain stem tumours.  Neuroradiology. 1997;  39 642-653
    CrossrefPubMedGoogle Scholar
  • 5 Bonawitz C, Castillo M, Chin C T, Mukherji S K, Barkovich A J. Usefulness of contrast material in MR of patients with neurofibromatosis type 1.  AJNR Am J Neuroradiol. 1998;  19 541-546
    PubMedGoogle Scholar
  • 6 Broniscer A, Gajjar A, Bhargava R, Langston J W, Heideman R, Jones D. et al . Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.  Neurosurgery. 1997;  40 331-338
    CrossrefPubMedGoogle Scholar
  • 7 Brown E W, Riccardi V M, Mawad M, Handel S, Goldman A, Bryan R N. MR imaging of optic pathways in patients with neurofibromatosis.  AJNR Am J Neuroradiol. 1987;  8 1031-1036
    PubMedGoogle Scholar
  • 8 Cawthon R M, Weiss R, Xu G, Viskochil D, Culver M, Stevens J. et al . A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations.  Cell. 1990;  62 193-201
    CrossrefPubMedGoogle Scholar
  • 9 Curless R G, Siatkowski M, Glaser J S, Shatz N J. MRI diagnosis of NF-1 in children without café-au-lait skin lesions.  Pediatr Neurol. 1998;  18 269-271
    CrossrefPubMedGoogle Scholar
  • 10 DeBella K, Poskitt K, Szudek J, Friedman J M. Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children.  Neurology. 2000;  54 1646-1650
    PubMedGoogle Scholar
  • 11 DiMario F J, Ramsby G, Greenstein R, Langshur S, Dunham B. Neurofibromatosis type 1: magnetic resonance imaging findings.  J Child Neurol. 1993;  8 32-39
    PubMedGoogle Scholar
  • 12 DiMario F J, Ramsby G. Magnetic resonance imaging lesion analysis in neurofibromatosis type 1.  Arch Neurol. 1998;  55 500-505
    CrossrefPubMedGoogle Scholar
  • 13 DiPaolo D P, Zimmerman R A, Rorke L B, Zackai E H, Bilaniuk L T, Yachnis A T. Neurofibromatosis type 1: Pathologic substrate of high-signal-intensity foci in the brain.  Radiology. 1995;  195 721-724
    CrossrefPubMedGoogle Scholar
  • 14 Duffner P K, Cohen M E, Seidel F G, Shucard D W. The significance of MRI abnormalities in children with neurofibromatosis.  Neurology. 1989;  39 373-378
    PubMedGoogle Scholar
  • 15 Hashimoto T, Tayama M, Miyazaki M, Kuroda Y, Hiura K, Hujino K. et al . Cranial MR findings in patients with von Recklinghausen's disease (neurofibromatosis type 1).  Neuropediatrics. 1990;  21 193-198
    PubMedGoogle Scholar
  • 16 Itoh T, Magnaldi S, White R M, Denckla M B, Hofman K, Naidu S. et al . Neurofibromatosis type 1: The evolution of deep gray and white matter MR abnormalities.  AJNR Am J Neuroradiol. 1994;  15 1513-1519
    PubMedGoogle Scholar
  • 17 Kim G, Mehta M, Kucharczyk W, Blaser S. Spontaneous regression of a tectal mass in neurofibromatosis 1.  AJNR Am J Neuroradiol. 1998;  19 1137-1139
    PubMedGoogle Scholar
  • 18 Leisti E-L, Pyhtinen J, Pöyhönen M. Spontaneous decrease of a pilocytotic astrocytoma in neurofibromatosis type 1.  AJNR Am J Neuroradiol. 1996;  17 1691-1694
    PubMedGoogle Scholar
  • 19 Menor F, Marti-Bonmati L, Arana E, Poyatos C, Cortina H. Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings.  Eur J Radiol. 1998;  26 121-131
    CrossrefPubMedGoogle Scholar
  • 20 Mirowitz S A, Sartor K, Gado M. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.  AJR Am J Roentgenol. 1990;  154 369-373
    CrossrefPubMedGoogle Scholar
  • 21 National Institutes of Health Consensus Developmental Conference . Neurofibromatosis. Conference statement.  Arch Neurol. 1988;  45 575-578
    CrossrefPubMedGoogle Scholar
  • 22 Norfray J F, Darling C, Byrd S, Ross B D, Schwalm C, Miller R. et al . Short TE proton MRS and neurofibromatosis type 1 intracranial lesions.  J Comput Assist Tomogr. 1999;  23 994-1003
    CrossrefPubMedGoogle Scholar
  • 23 North K. Neurofibromatosis type 1 in childhood. London; Mac Keith Press for the International Child Neurology Association 1997
    Google Scholar
  • 24 Pollack I F, Shultz B, Mulvihill J J. The management of brain stem gliomas in patients with neurofibromatosis type 1.  Neurology. 1996;  46 1652-1660
    CrossrefPubMedGoogle Scholar
  • 25 Rosenbaum T, Engelbrecht V, Krölls W, van Dorsten F A, Hoehn-Berlage M, Lenard H-G. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice.  Brain Dev. 1999;  21 268-273
    CrossrefPubMedGoogle Scholar
  • 26 Rosenbaum T, Kim H A, Boissy Y L, Ling B, Ratner N. Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate PO expression and myelination.  Ann N Y Acad Sci. 1999;  883 203-214
    CrossrefPubMedGoogle Scholar
  • 27 Rossi L N, Triulzi F, Parazzini C, Maninetti M M. Spontaneous improvement of optic pathway lesions in children with neurofibromatosis type 1.  Neuropediatrics. 1999;  30 205-209
    PubMedGoogle Scholar
  • 28 Schmandt S M, Packer R J, Vezina L G, Jane J. Spontaneous regression of low-grade astrocytomas in childhood.  Pediatr Neurosurg. 2000;  32 132-136
    CrossrefPubMedGoogle Scholar
  • 29 Sevick R J, Barkovich A J, Edwards M SB, Koch T, Berg B, Lempert T. Evolution of white matter lesions in neurofibromatosis type 1: MR findings.  AJR Am J Roentgenol. 1992;  159 171-175
    PubMedGoogle Scholar
  • 30 Terada H, Barkovich A J, Edwards M SB, Ciricillo S F. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1.  AJNR Am J Neuroradiol. 1996;  17 755-760
    PubMedGoogle Scholar
  • 31 Xu G, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R. et al . The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae.  Cell. 1990;  63 835-841
    CrossrefPubMedGoogle Scholar

Prof. Raili Raininko

Department of Radiology · University Hospital

75185 Uppsala

Sweden

Email: raili.raininko@radiol.uu.se

      >